EP300/CREBBP acetyltransferase inhibition limits steroid receptor and FOXA1 signaling in prostate cancer cells

Jasmin Huttunen(University of Eastern Finland), Ville Paakinaho(National Institutes of Health)
Cellular and Molecular Life Sciences
April 2, 2024
Cited by 10


Related Papers